Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples.
The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time
Download PDF (Metabolomics Market):
This research report segments this Metabolomics Market based on product and service, application, indication, and region.
Major Market Drivers in Metabolomics Market:
- Availability of government and private funding
- Increasing pharmaceutical and biotech R&D expenditure
- Technological advancements
- Growing demand for personalized medicine
- Increasing use of metabolomics in toxicology testing
Speak to Our Research Expert (Metabolomics):
Key Market Growth Trend in Metabolomics:
The growing use of hyphenated technologies is likely to provide the largest growth opportunity for metabolomics market players.
Over the past four years, several hyphenated systems have been launched by market players. Hyphenated technology is a combination of two or more analytical tools. Hyphenated technologies reduce cost by requiring the installation of a single instrument. They also provide ease of operation and require lesser space as compared to the installation of two or more standalone devices. In addition, these technologies have broadened the applications of analytical techniques in the analysis of biomaterials, especially natural products.
Metabolomics Market Based on Application;
On the basis of application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. the biomarker discovery segment accounted for the largest share of the global metabolomics market.
This is mainly attributed to the improvement in both the efficiency and reliability of metabolic profiling of biomarkers and the accurate and clinically useful diagnostic capabilities of metabolic biomarkers for the management of diseases at the metabolic level.
Major Key Players in Metabolomics Market;
Prominent players in the global metabolomics market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.),
Most of the leading players in this market are based in developed countries across North America and Europe.
Request Research Sample Pages (Metabolomics Market):